Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial

Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial

(2017) Özlen Emekçi Özay et al.   GYNECOLOGICAL ENDOCRINOLOGY

Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)

(2016) Franca Fruzzetti et al.   GYNECOLOGICAL ENDOCRINOLOGY

Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials

(2016) Vittorio Unfer et al.   International Journal of Endocrinology

Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study

(2013) P. G. Artini et al.   GYNECOLOGICAL ENDOCRINOLOGY

Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review

(2009) Stefano Palomba et al.   ENDOCRINE REVIEWS

Contribution of myo-inositol to reproduction

(2009) E. Papaleo et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women

(2009) Emanuela Raffone et al.   GYNECOLOGICAL ENDOCRINOLOGY

Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial

(2008) Enrico Papaleo et al.   FERTILITY AND STERILITY

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

(2008) Alessandro D. Genazzani et al.   GYNECOLOGICAL ENDOCRINOLOGY